Security
Clover Health Investments, Corp. Class A Common Stock · CLOV
CLOVNASDAQCommon stockCurrentCIK 1801170Updated Oct 21, 2026
Name history
Social Capital Hedosophia Holdings Corp. III · through Jan 7, 2021
CLOV price & chart
Loading TradingView…
NASDAQ:CLOV on TradingView ↗In the news
Recent filings
Regulation FD Disclosure
Items 7.01, 9.01
4 filing
3 filing
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02, 9.01
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
Items 5.02, 9.01
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | Q1 2024 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 559,659,000Source | 653,013,000Source | 720,326,000Source | 574,987,000Source | 674,210,000Source | 697,728,000Source | 583,717,000Source | 671,770,000Source | 541,011,000Source | 580,742,000Source | 570,671,000Source | 808,620,000Source |
| Property, Plant and Equipment, NetUSD | 5,487,000Source | 5,336,000Source | 7,231,000Source | 5,201,000Source | 5,276,000Source | 6,904,000Source | 5,026,000Source | 5,209,000Source | 6,385,000Source | 5,307,000Source | 5,082,000Source | 5,753,000Source |
| GoodwillUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 11,749,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | — | 287,956,000Source | — | — | 254,771,000Source | — | — | 208,255,000Source | 78,301,000Source | 194,543,000Source | 122,863,000Source | 103,791,000Source |
| Assets, CurrentUSD | 330,920,000Source | 432,727,000Source | 485,446,000Source | 362,939,000Source | 549,576,000Source | 448,021,000Source | 331,409,000Source | 552,737,000Source | 307,855,000Source | 343,124,000Source | 427,970,000Source | 624,997,000Source |
| Operating Lease, Right-of-Use AssetUSD | — | 2,585,000Source | — | — | 2,858,000Source | — | — | 3,124,000Source | — | — | 3,382,000Source | 4,025,000Source |
| Other Assets, NoncurrentUSD | 27,196,000Source | 10,996,000Source | 24,745,000Source | 15,861,000Source | 9,746,000Source | 25,129,000Source | 13,539,000Source | 9,785,000Source | 24,118,000Source | 13,259,000Source | 10,246,000Source | 15,735,000Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 218,727,000Source | 310,847,000Source | 344,069,000Source | 230,808,000Source | 349,322,000Source | 358,302,000Source | 247,642,000Source | 379,296,000Source | 232,307,000Source | 239,599,000Source | 284,277,000Source | 460,882,000Source |
| Stockholders’ equity: | ||||||||||||
| Additional Paid in CapitalUSD | 2,656,432,000Source | 2,546,167,000Source | 2,706,640,000Source | 2,630,021,000Source | 2,517,959,000Source | 2,695,144,000Source | 2,603,123,000Source | 2,490,036,000Source | 2,682,663,000Source | 2,576,471,000Source | 2,461,238,000Source | 2,319,157,000Source |
| Retained Earnings (Accumulated Deficit)USD | -2,239,032,000Source | -2,180,711,000Source | -2,233,017,000Source | -2,214,655,000Source | -2,171,556,000Source | -2,261,018,000Source | -2,204,077,000Source | -2,178,964,000Source | -2,288,352,000Source | -2,202,803,000Source | -2,159,794,000Source | -1,955,582,000Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | 471,000Source | 852,000Source | -1,551,000Source | 177,000Source | -2,259,000Source | -672,000Source | -74,000Source | -2,560,000Source | 528,000Source | -1,584,000Source | -2,370,000Source | -9,374,000Source |
| Stockholders' Equity Attributable to ParentUSD | — | — | 376,257,000Source | 344,179,000Source | — | 339,426,000Source | 336,075,000Source | — | — | — | — | 347,738,000Source |
| Liabilities and EquityUSD | 559,659,000Source | 653,013,000Source | 720,326,000Source | 574,987,000Source | 674,210,000Source | 697,728,000Source | 583,717,000Source | 671,770,000Source | 541,011,000Source | 580,742,000Source | 570,671,000Source | 808,620,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 193,447,000Source | 279,635,000Source | 323,330,000Source | 201,948,000Source | 324,511,000Source | 336,583,000Source | 215,653,000Source | 356,389,000Source | 208,823,000Source | 213,516,000Source | 261,115,000Source | 440,656,000Source |
| Operating Lease, Liability, CurrentUSD | — | 1,345,000Source | — | — | 1,491,000Source | — | — | 1,623,000Source | — | — | 1,665,000Source | 1,827,000Source |
| Operating Lease, Liability, NoncurrentUSD | — | 2,321,000Source | — | — | 2,519,000Source | — | — | 2,717,000Source | — | — | 2,998,000Source | 4,033,000Source |
| Other Liabilities, NoncurrentUSD | 25,280,000Source | 28,891,000Source | 20,739,000Source | 28,860,000Source | 22,292,000Source | 21,719,000Source | 31,989,000Source | 20,190,000Source | 23,484,000Source | 26,083,000Source | 20,164,000Source | 16,193,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Additional Financial Items | ||||||||||||
| Long-term Debt, Excluding Current MaturitiesUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
cash flow · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | -24,377,000Source | -9,155,000Source | — | -10,578,000Source | — | -1,274,000Source | -85,549,000Source | -43,009,000Source | -213,361,000Source | -338,844,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation and amortization | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 12,271,000Source | 26,437,000Source | 103,657,000Source | 114,331,000Source | 140,931,000Source | 164,305,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -21,392,000Source | 1,990,000Source | 43,327,000Source | -12,625,000Source | -6,443,000Source | 22,565,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | 107,895,000Source | -16,293,000Source | -66,934,000Source | 34,845,000Source | -115,871,000Source | -203,926,000Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | 16,200,000Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -5,068,000Source | 8,930,000Source | 4,076,000Source | 565,000Source | 140,013,000Source | 95,133,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 854,000Source | 185,000Source | 2,043,000Source | 1,556,000Source | 584,000Source | 4,467,000Source |
| Cash flows from financing activities: | ||||||||||||
| Payments for Repurchase of Common StockUSD | — | — | — | — | — | — | 0Source | 18,297,000Source | 18,298,000Source | 1,772,000Source | 6,220,000Source | 6,362,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | -7,863,000Source | -31,741,000Source | -53,384,000Source | -17,361,000Source | -33,861,000Source | -4,962,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 94,964,000Source | -39,104,000Source | -116,242,000Source | 18,049,000Source | -9,719,000Source | -113,755,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | — | — | 190,055,000Source | 287,956,000Source | 198,837,000Source | 188,648,000Source | 173,265,000Source | 155,439,000Source | 78,301,000Source | 194,543,000Source | 176,494,000Source | 186,213,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 0Source |
| Income Taxes Paid, NetUSD | — | — | — | — | — | — | — | — | 0Source | — | — | — |
| Additional Financial Items | ||||||||||||
| AmortizationUSD | — | — | — | — | — | — | — | — | 1,500,000Source | 1,200,000Source | 1,000,000Source | 800,000Source |
| Share-based Payment Arrangement, ExpenseUSD | — | — | 26,106,000Source | 27,988,000Source | 8,904,000Source | 26,195,000Source | 12,451,000Source | 26,437,000Source | 103,657,000Source | 114,331,000Source | 140,931,000Source | 164,305,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | 30,000Source |
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | — | — | — | 100,000Source |
| DepreciationUSD | — | — | — | — | — | — | — | — | 200,000Source | 200,000Source | 400,000Source | 400,000Source |
| Depreciation, Amortization and Accretion, NetUSD | — | — | — | — | — | — | -441,000Source | -437,000Source | -1,843,000Source | -2,524,000Source | -4,014,000Source | -1,503,000Source |
| Derivative, Gain (Loss) on Derivative, NetUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Gain (Loss) on InvestmentsUSD | — | — | 0Source | 0Source | — | 0Source | — | 0Source | 0Source | -467,000Source | -4,726,000Source | 9,217,000Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | 23,326,000Source |
| General and Administrative ExpenseUSD | — | — | 48,953,000Source | 35,201,000Source | 70,299,000Source | 48,484,000Source | 74,629,000Source | 50,675,000Source | 214,270,000Source | 176,480,000Source | 187,571,000Source | 207,917,000Source |
| GoodwillUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 11,749,000Source |
| Goodwill and Intangible Asset ImpairmentUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 15,945,000Source | 0Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 11,749,000Source | 0Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | -24,377,000Source | -8,785,000Source | 28,001,000Source | -10,578,000Source | 27,334,000Source | -1,274,000Source | -85,549,000Source | -46,266,000Source | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | 0Source | -370,000Source | — | 0Source | — | 0Source | 0Source | 3,257,000Source | — | — |
| Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| InterestExpenseNonoperatingUSD | — | — | — | 0Source | — | — | — | — | 0Source | 0Source | — | — |
| Liability for Unpaid Claims and Claims Adjustment Expense, Incurred ClaimsUSD | — | — | — | — | — | — | 576,580,000Source | 346,376,000Source | 1,533,456,000Source | 985,592,000Source | 987,158,000Source | 984,031,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -24,377,000Source | -9,155,000Source | 28,001,000Source | -10,578,000Source | 27,334,000Source | -1,274,000Source | -85,549,000Source | -43,009,000Source | -213,361,000Source | -338,844,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | — | — | -213,361,000Source | -338,844,000Source |
| Operating ExpensesUSD | — | — | 521,027,000Source | 339,771,000Source | 715,166,000Source | 488,179,000Source | 721,855,000Source | 463,605,000Source | 2,009,837,000Source | 1,416,880,000Source | 2,242,262,000Source | 3,847,611,000Source |
| Payments for Repurchase of WarrantsUSD | — | — | — | — | — | — | — | — | — | — | 0Source | 0Source |
| Payments of Financing CostsUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Payments to Acquire InvestmentsUSD | — | — | — | — | — | — | 40,915,000Source | 33,169,000Source | 205,097,000Source | 201,241,000Source | 175,567,000Source | 369,396,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | — | — | 1,096,000Source | 193,000Source | 0Source | 0Source |
| Proceeds from (Payments to) Noncontrolling InterestsUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Realized Investment Gains (Losses)USD | — | — | 188,000Source | 170,000Source | 2,000Source | 394,000Source | 28,000Source | 42,000Source | 979,000Source | 480,000Source | 20,000Source | -267,000Source |
| Restructuring CostsUSD | — | — | 0Source | -538,000Source | — | 0Source | — | 0Source | 0Source | 288,000Source | 9,931,000Source | — |
| Deferred Policy Acquisition Costs, Amortization Expense | — | — | — | — | —Source | —Source | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2025 | Q4 2024 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 496,650,000Source | 330,986,000Source | 743,167,000Source | 477,620,000Source | 749,189,000Source | 462,331,000Source | 1,924,308,000Source | 1,371,131,000Source | 2,033,720,000Source | 3,476,687,000Source |
| Operating Income (Loss)USD | — | — | -24,377,000Source | -8,785,000Source | 28,001,000Source | -10,559,000Source | 27,334,000Source | -1,274,000Source | -85,529,000Source | -45,749,000Source | -208,542,000Source | -370,924,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | — | — | — | — | — | — | -85,549,000Source | — | — | — |
| Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -24,377,000Source | -9,155,000Source | 28,001,000Source | -10,578,000Source | 27,334,000Source | -1,274,000Source | -85,549,000Source | -43,009,000Source | -213,361,000Source | -338,844,000Source |
| Earnings Per Share, BasicUSD per share | — | — | — | — | 0.05Source | -0.02Source | 0.05Source | 0Source | — | — | -0.44Source | -0.71Source |
| Earnings Per Share, DilutedUSD per share | — | — | — | — | 0.05Source | -0.02Source | 0.05Source | 0Source | — | — | -0.44Source | -0.71Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 512,743,521Source | 490,180,103Source | 524,186,885Source | 509,043,210Source | 522,184,385Source | 497,056,331Source | 511,967,146Source | 490,018,730Source | 482,176,127Source | 476,244,262Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 512,743,521Source | 490,180,103Source | 545,447,735Source | 509,043,210Source | 532,501,448Source | 497,056,331Source | 511,967,146Source | 490,018,730Source | 482,176,127Source | 476,244,262Source |
| Interest Expense (non-operating)USD | — | — | — | 0Source | — | — | — | — | 0Source | 0Source | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | — | — | — | — | — | — | — | — | — | 100,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | 406,000Source | 339,000Source | 564,000Source | 394,000Source | 515,000Source | 466,000Source | 1,686,000Source | 1,331,000Source | 2,509,000Source | 1,187,000Source |
| Gain (Loss) on InvestmentsUSD | — | — | 0Source | 0Source | — | 0Source | — | 0Source | 0Source | -467,000Source | -4,726,000Source | 9,217,000Source |
| General and Administrative ExpenseUSD | — | — | 48,953,000Source | 35,201,000Source | 70,299,000Source | 48,484,000Source | 74,629,000Source | 50,675,000Source | 214,270,000Source | 176,480,000Source | 187,571,000Source | 207,917,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 11,749,000Source | 0Source |
| Gross ProfitUSD | — | — | — | 81,212,000Source | — | — | — | — | — | — | 257,332,000Source | 22,735,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -85,574,000Source | — | — | — |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | -24,377,000Source | -8,785,000Source | 28,001,000Source | -10,578,000Source | 27,334,000Source | -1,274,000Source | -85,549,000Source | -46,266,000Source | — | — |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | — | — | -0.05Source | -0.02Source | — | -0.02Source | — | 0Source | -0.17Source | -0.09Source | — | — |
| Income (Loss) from Continuing Operations, Per Diluted ShareUSD per share | — | — | -0.05Source | -0.02Source | — | -0.02Source | — | 0Source | -0.17Source | -0.09Source | — | — |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | — | — | 0Source | -370,000Source | — | 0Source | — | 0Source | 0Source | 3,257,000Source | — | — |
| Interest ExpenseUSD | — | — | — | — | — | — | — | — | — | — | 7,000Source | 1,333,000Source |
| Labor and Related ExpenseUSD | — | — | 48,195,000Source | 54,995,000Source | 54,138,000Source | 61,309,000Source | 57,063,000Source | 59,022,000Source | 225,475,000Source | 232,454,000Source | 257,157,000Source | 278,725,000Source |
| Liability for Unpaid Claims and Claims Adjustment Expense, Incurred ClaimsUSD | — | — | — | — | — | — | 576,580,000Source | 346,376,000Source | 1,533,456,000Source | 985,592,000Source | 987,158,000Source | 984,031,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | — | — | — | — | — | — | — | — | -213,361,000Source | -338,844,000Source |
| Net Income (Loss) from Continuing Operations Available to Common Shareholders, BasicUSD | — | — | — | -8,785,000Source | — | — | — | — | — | -46,266,000Source | — | — |
| Net Investment IncomeUSD | — | — | 5,272,000Source | 6,819,000Source | 4,507,000Source | 4,682,000Source | 4,318,000Source | 4,608,000Source | 18,806,000Source | 22,754,000Source | 18,374,000Source | 7,543,000Source |
| Operating ExpensesUSD | — | — | 521,027,000Source | 339,771,000Source | 715,166,000Source | 488,179,000Source | 721,855,000Source | 463,605,000Source | 2,009,837,000Source | 1,416,880,000Source | 2,242,262,000Source | 3,847,611,000Source |
| Other General ExpenseUSD | — | — | — | — | — | — | — | — | — | 0Source | 0Source | 70,000Source |
| Realized Investment Gains (Losses)USD | — | — | 188,000Source | 170,000Source | 2,000Source | 394,000Source | 28,000Source | 42,000Source | 979,000Source | 480,000Source | 20,000Source | -267,000Source |
| Restructuring CostsUSD | — | — | 0Source | -538,000Source | — | 0Source | — | 0Source | 0Source | 288,000Source | 9,931,000Source | — |
| Revenue Not from Contract with Customer, OtherUSD | — | — | 17,522,000Source | 8,407,000Source | 5,400,000Source | 7,794,000Source | 5,000,000Source | 5,425,000Source | 32,576,000Source | 26,250,000Source | 24,774,000Source | 11,683,000Source |
| Deferred Policy Acquisition Costs, Amortization Expense | — | — | — | — | —Source | —Source | — | — | — | — | — | — |
Filing attachments
ex991-pressreleasedatedj.htm · 8-K · 2026-01-14
Clover Health Announces 53% Growth in Medicare Advantage Membership During AEP, Increasing to 153,000 Members as of January 1, 2026; Expects First-Ever Full Year GAAP Net Income Profitability in 2026 ● Clover delivers market-leading Medicare Advantage growth, establishing a strong path to achieve its first-ever full year GAAP Net Income profitability in 2026. ● Disciplined, core-market growth, strong returning member retention, and improving cohort economics position Clover for compounding earni…
Read attachment ↗ex992-slidepresentationd.htm · 8-K · 2026-01-14
Investor Presentation January 2026 LGTMs: Date: Andrew T. (CEO) LGTM 1/8/26 Peter K. (CFO) LGTM 1.7.26 Karen S. (Legal) LGTM 1.7.26 This presentation and the accompanying oral presentation include forward-looking statements, including, without limitation, statements regarding future events and Clover Health Investments, Corp.’s (“Clover Health,” “we,” “our,” or “us”) expectations regarding GAAP Net Income, Adjusted EBITDA, Adjusted Net income from continuing operations, Adjusted SG&A, Adjusted …
Read attachment ↗